Pulsalys

What Pulsalys does

Pulsalys is a French technology transfer acceleration company (Société d'Accélération du Transfert de Technologies, or SATT) headquartered in Villeurbanne, serving the Lyon and Saint-Etienne academic ecosystem. Founded in December 2013 under the Programme d'Investissements d'Avenir (PIA) with €1M in capital, it identifies scientific discoveries from University of Lyon member laboratories — including Université Claude Bernard Lyon 1, Université Jean Monnet, ENS Lyon, INSA Lyon, and CNRS-affiliated labs — and transfers them to industry through two channels: exclusive licensing agreements with established companies and equity-backed startup creation. Its portfolio spans eight institutional framework agreements and a diversified technology offer catalogue including AUDIOFOCUS (embedded AI for sound source recognition), CELLSTRESS (AI plus brightfield microscopy for cell mechanical resistance, TRL 3-4), TIPi (computerized pragmatic inference test for autism screening, validated on 300+ children, TRL 6), CANN (CNN optimization), DECOTEX (deep eutectic solvent textile decolorization), Silicone recycling via re-reticulation, and Skinréacteur (bioreactor for tissue maturation). Underlying technologies are protected through granted and pending patents (e.g., FR N°2209653 for CELLSTRESS) and proprietary know-how packages.

Pulsalys generates revenue primarily through licensing royalties on transferred technologies and equity stakes in the 60+ startups it has co-founded since inception, including NH TherAguix, Keranova, Lactips, Microlight3D, OncoFactory, Polyvalan, and Smartery. Its core operating budget flows from public funding programs (PIA, France 2030), supplemented by returns from licensing (e.g., Théa Pharmaceuticals, BIOASTER IRT, Activation, Arskan, E-attract). Go-to-market is sales-led through direct researcher engagement (Ateliers de la Valorisation, calls for projects), complemented by ecosystem partnerships with competitiveness clusters (AXELERA, Imaginove, Cancéropôle CLARA) and co-incubation with 1Kubator via the 1KTech program.

Pulsalys's customer base is structurally tripartite: academic researchers seeking IP protection and commercialization support, deep tech entrepreneurs requiring incubation and seed capital, and industrial partners (predominantly regional pharma, biotech, chemicals, and materials firms) licensing innovation for product development. The organization is privately held as a SAS with three principal shareholders including CNRS, governed by a board chaired by current President Valérie Mazza (since succeeding Sophie Jullian), with investment leadership under Directeur des Investissements Olivier Solinas. Headcount sits in the 11-50 band, consistent with a lean technology transfer operator rather than a scaling venture-backed entity.

Name

Pulsalys

Legal name

PULSALYS

Website

https://pulsalys.fr

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

11–50 employees

Short description

Pulsalys is a French SATT (technology transfer accelerator) that transforms scientific discoveries from Lyon-Saint-Etienne academic laboratories into commercial products via licensing and equity-backed startup creation. It serves academic researchers, deep tech entrepreneurs, and industrial partners through its public-funded maturation platform.

Ownership category

akta.pro rank

Product category

Technology Transfer Services

NAICS

Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Testing Laboratories and Services (54138)

SIC

Patent Owners & Lessors (6794), Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)

akta.pro primary industry

Technology Transfer & Innovation-Driven Research Universities (High Commercialization) (EDAHABAH)

Keywords

• Technology transfer services
• Deep tech incubation
• Academic technology licensing
• Startup acceleration programs
• Research commercialization

Headquarters

HQ city

Villeurbanne

HQ country

France

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Others

Revenue model

1. Technology Transfer & Licensing: Pulsalys generates revenue through licensing technologies to existing companies and through equity stakes in startups it helps create. The organization invests in maturation projects funded by public programmes (PIA/France 2030) and generates returns through license fees, royalties, and equity appreciation.
2. Incubation & Acceleration Services: Pulsalys provides incubation and acceleration support to deep tech startups emerging from academic research, investing directly in equity and providing operational support in exchange for ownership stakes.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

Pulsalys is a French Société d'Accélération du Transfert de Technologies (SATT) that invests public funding into maturing early-stage discoveries from public research laboratories in the Lyon-Saint-Étienne region into market-ready innovations. Its core offerings are technology licensing to industrial partners and the creation and incubation of startups spun off from academic research, supported by an internal proof-of-concept investment fund. The organization manages intellectual property end-to-end and acts as an intermediary between public science and private commercialization.

Product overview

Pulsalys is an incubator and accelerator for deeptech innovations operating as a Technology Transfer Acceleration Company (SATT) for the Lyon and Saint-Etienne region. Rather than offering a unified software product, Pulsalys provides a portfolio of technology transfer services encompassing technology maturation support and a diverse portfolio of technology offers (offres de technologie) spanning multiple sectors including healthcare/diagnostics, materials science, cleantech, and digital technologies. Key technology offerings include TIPi for neurodevelopmental assessment, CELLSTRESS for cell analysis, AUDIOFOCUS for audio AI, CANN for neural network optimization, DECOTEX for textile recycling, and Skinréacteur for tissue maturation. Pulsalys also supports startups including CORNEALIFE, IDISCOVR, Fabera, AIoTrust, Osta Therapeutics, KAOMX, Smartery, Regenaxis Therapeutics, REVENTUS PHARMA, ELECSYOR, H&B MATERIALS, and Novaleum.

Differentiator

Problem solved

Functional benefit

Products and services

• Technology Maturation Investment Service Investment funding and project management to bring early-stage academic discoveries (typically TRL 2–4) from public laboratories up to demonstrable proof-of-concept, for use by researchers and laboratories in the Lyon-Saint-Étienne ecosystem.
• Intellectual Property Protection and Licensing Service End-to-end patent protection and licensing of academic technologies to industrial partners, for public research institutions and corporate licensees seeking validated, protected deep-tech IP.
• Startup Creation and Incubation Program Creation, equity participation in, and operational incubation of deep-tech startups spun off from public research, for academic researchers and entrepreneurs building science-based companies.
• TIPi Technology Offer

Quantifiable outcome

• 400+ M€ invested in projects
• +5 more outcomes

Named customers20 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability8 records

Feature5 records

Partnerships

18 partnerships are on record, tiered core, moderate, flagship and major.

• CNRScoreStrategic or Co-development Partner · 26 June 201810-year bilateral framework convention signed on 26 June 2018 (effective from 26/10/18) defining collaboration rules for intellectual property, exploitation contracts, and co-maturation of projects. CNRS is one of PULSALYS' three shareholders and has been a key strategic partner since the organization's inception.
• Université de Lyon (IDEXLYON)coreStrategic or Co-development Partner · 1 June 2018IDEXLYON is the University of Lyon's IDEX project vehicle. Together with PULSALYS, it launched the joint 'Tech 4 Inclusion' call for projects to identify and develop research results for improving quality of life for people with disabilities. Eight bilateral framework agreements between PULSALYS and IDEX member institutions guarantee privileged access to research results.
• Linksium (SATT Grenoble)moderateStrategic or Co-development Partner · 1 January 2018PULSALYS collaborated with its Grenoble counterpart Linksium on the Microlight3D project, which won the Grand Prix I-LAB 2018.
• Cancéropôle CLARAflagshipStrategic or Co-development Partner · 1 December 2017A partnership convention was signed between PULSALYS and the Cancéropôle CLARA, formalizing their active multi-year collaboration in oncology research valorization. Joint initiatives include the Research2Business Oncology Meeting and the OncoStarter detection programme.
• Université Lumière-Lyon 2coreStrategic or Co-development Partner · 1 October 2017Framework agreement signed expanding PULSALYS' bilateral agreements to 8 with University of Lyon member institutions, guaranteeing privileged access to research results for transfer to the economic world.
• ENTPEcoreStrategic or Co-development Partner · 1 October 2017Framework agreement with ENTPE (Ecole Nationale des Travaux Publics de l'Etat) signed alongside Université Lumière-Lyon 2, bringing total bilateral agreements to 8.
• Hub RecherchecoreStrategic or Co-development Partner · 1 September 2017Hub Recherche is a platform that centralizes expertise from research laboratories across the Lyon-Saint-Etienne site, facilitating industrial access to academic research. PULSALYS leverages it to identify expert laboratories worldwide and connect companies with relevant researchers.
• BeelysmoderateStrategic or Co-development Partner · 1 July 2017SAMESAME was co-incubated by Beelys, Université Lyon 3, and PULSALYS. PULSALYS invested €110,000 in the project and took an equity stake at the company's creation.
• BIOASTER (IRT)coreTechnology or Integration · 1 January 2017PULSALYS signed a licensing agreement with IRT BIOASTER concerning a patented solution for washing native biofilms, as a concrete outcome of their partnership convention. BIOASTER is a public-interest research institute focused on infectious diseases and microbiology.
• 1Kubator / 1KTechmajorStrategic or Co-development Partner · 1 January 2017PULSALYS and 1Kubator jointly operate the '1KTech' incubation programme combining PULSALYS' deep tech science transfer expertise with 1Kubator's startup creation methodology. The programme supports the creation of deep tech companies in the Lyon region.
• AXELERAmajorStrategic or Co-development Partner · 1 January 2017AXELERA is the Auvergne-Rhône-Alpes competitiveness cluster for chemistry and environment. The partnership with PULSALYS operates at multiple levels: orienting mature technologies toward AXELERA's industrial network, providing project engineering for maturation, and offering startups access to the cluster's network, EIP funding label, and visibility on national/international trade shows.
• ImaginovemoderateStrategic or Co-development Partner · 1 January 2017Imaginove is the regional competitiveness cluster for digital content and uses, bringing together ~200 companies, schools, and research labs in gaming, culture, and wellbeing sectors. PULSALYS collaborates with Imaginove to support innovative digital projects emerging from research.
• Université Lyon 3 / IAE LyonmoderateStrategic or Co-development Partner · 1 January 2017Co-incubation partner for SAMESAME startup alongside Beelys and PULSALYS, contributing to the entrepreneurial ecosystem around the University of Lyon.
• Laboratoire Théa / SinclerflagshipOEM/ Whitelabel/ Licensing Partner · 1 June 2016PULSALYS signed a licensing agreement with Théa laboratories (Europe's leading independent ophthalmology pharma group) for technology transfer from BiiGC lab in cornea transplantation. This led to the creation of the subsidiary Sincler, based in Saint-Etienne.
• Université Claude Bernard Lyon 1coreStrategic or Co-development Partner · 1 January 2013As a founding member of the SATT PULSALYS ecosystem, Université Claude Bernard Lyon 1 is among the eight member institutions with bilateral framework agreements enabling PULSALYS to access and transfer its research outputs.
• Université Jean Monnet (Saint-Etienne)coreStrategic or Co-development Partner · 1 January 2013Université Jean Monnet in Saint-Etienne, a founding member institution, works with PULSALYS to transfer research from its labs (including BiiGC and IMP) into startups and industrial applications, with examples including Keranova and Lactips.
• Université de Lyon (UdL)coreStrategic or Co-development Partner · 1 January 2013PULSALYS was created as the SATT for the Université de Lyon site, which encompasses multiple institutions including ENS de Lyon, INSA Lyon, CPE Lyon, and others, all contributing research outputs for transfer.
• SATT Network (Le Réseau SATT)majorStrategic or Co-development Partner · 1 January 2013PULSALYS participates in the national SATT network, partnering on cross-regional initiatives including the Startup Booster (composites), TILT (mechanical industry with CETIM), and other shared programmes.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Cambridge Enterprise: University of Cambridge's technology transfer arm performing similar IP management, licensing, and equity-backed spin-out creation. Comparable operating model and revenue mix though on a globally elite research base.
• Oxford University Innovation: The University of Oxford's technology transfer company performing IP licensing, equity investment, and startup creation from academic research. Comparable in mission and business model to Pulsalys though operating at much larger scale in the UK.
• CNRS Innovation: The technology transfer subsidiary of CNRS, which is one of Pulsalys's three main shareholders. Operates a broader national remit for CNRS IP valorization and represents an institutional incumbent with overlapping capabilities.

Others

• Bpifrance: France's public investment bank and a key funder within the PIA / France 2030 ecosystem alongside Pulsalys. Not a direct competitor but a critical ecosystem participant that co-invests in many of Pulsalys's portfolio startups.

Direct peers

• SATT Sud-Est: French SATT covering the Aix-Marseille / Côte d'Azur academic ecosystem. Directly comparable in mandate, structure, and operating model to Pulsalys as a regional SATT.
• Linksium: SATT for the Grenoble ecosystem and a confirmed Pulsalys collaborator (joint work on Microlight3D which won Grand Prix I-LAB 2018). Same mandate, same revenue model (licensing + equity), same institutional backing structure.
• SATT Conectus Alsace: SATT for the Alsace academic site serving Strasbourg and Mulhouse research institutions. Directly comparable in operating model, deal flow, and revenue approach to Pulsalys.
• SATT Paris-Saclay: Another French Société d'Accélération du Transfert de Technologies operating under the same PIA framework. Both organizations perform technology maturation, IP protection, licensing, and equity-backed startup creation from public research — they are sibling SATTs serving different regional academic ecosystems.
• SATT Nord: SATT covering the Nord region of France with the same technology transfer, maturation, and equity investment model as Pulsalys, sourced from Lille-area universities and research institutes.
• INSA Transfert (INSAVALOR): Technology transfer office for the INSA university group with similar mandate to detect, mature and commercialize academic research. Comparable in scope to a single-institution SATT-style operator within the French ecosystem.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/Pulsalys
• YouTubeyoutube.com/channel/UCbBV-UXTO_X0GNs_9fsaSLQ
• LinkedInlinkedin.com/company/pulsalys

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments4 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pulsalys